Park Medi World Q2 FY'27 Revenue up 25% to ₹511 Cr; H1 FY'27 Revenue up 22% to ₹986.7 Cr
Park Medi World reported Q2 FY'27 revenue of ₹511 crore, a 25% YoY increase. H1 FY'27 revenue grew 22% YoY to ₹986.7 crore. The company added 680 beds in H1 FY'27, reaching a total capacity of 4,290 beds. Plans are in place to add another 1,430 beds in FY'27, marking a 40% capacity increase.
The announcement details strong financial performance and a significant expansion plan, which are material events for investors and stakeholders, indicating substantial future growth potential.
The company reported significant year-on-year revenue growth for both the quarter and the half-year, along with substantial bed capacity expansion. This indicates positive operational performance and strategic growth.
Park Medi World Limited has released its investor presentation for the financial results of the quarter and half-year ended September 30, 2026. The company reported a strong performance with Q2 FY'27 revenue rising by 25% year-on-year to ₹511 crore (₹5,110 million) and H1 FY'27 revenue increasing by 22% year-on-year to ₹986.7 crore (₹9,867 million).
During the first half of FY'27, the company added 680 beds through new facilities in Rudrapur and Panchkula, bringing its total bed capacity to 4,290. The management noted that the onboarding of this new capacity has had a near-term impact on occupancy and profitability, as new facilities require time to ramp up. Looking ahead, Park Medi World plans to add approximately 1,430 beds in FY'27 across five new facilities, including Febris (Delhi), Palam Vihar expansion (Gurugram), Mehar Hospital (Zirakpur), and the Kanpur facility. This expansion represents a significant addition of about 40% over its FY'26 closing capacity.
The company's priorities are the seamless integration of these new assets, improving utilization, and enhancing margins. Park Medi World maintains a strong balance sheet with ₹3,713 million in cash against ₹1,779 million in term debt, positioning it to fund growth while remaining committed to affordable, high-quality healthcare.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.